Molecular and Cellular Therapies View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2013

PUBLISHER

BioMed Central

LANGUAGE

en

HOMEPAGE

http://molcelltherapies.biomedcentral.com/

Recent publications latest 20 shown

  • 2016-12 Albumin-based drug delivery: harnessing nature to cure disease
  • 2016-12 The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia
  • 2016-12 Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory molecules
  • 2015-12 Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling
  • 2015-12 Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
  • 2015-12 Cross talk of the first-line defense TLRs with PI3K/Akt pathway, in preconditioning therapeutic approach
  • 2015-12 Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets
  • 2015-12 A prospective, randomized, three arm, open label study comparing the safety and efficacy of PP110, a novel treatment for hemorrhoids to preparation-H® maximum strength cream in the treatment of grade 2–3 hemorrhoids
  • 2015-12 Polymeric nanocarriers for the treatment of systemic iron overload
  • 2015-12 Proteomic analysis of extracellular vesicles from medullospheres reveals a role for iron in the cancer progression of medulloblastoma
  • 2015-12 The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target
  • 2014-12 Gene therapy for cancer: present status and future perspective
  • 2014-12 Harnessing RNAi nanomedicine for precision therapy
  • 2014-12 Therapeutic opportunities for targeting microRNAs in cancer
  • 2014-12 Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy
  • 2014-12 Application of circulating tumor cells scope technique on circulating tumor cell research
  • 2014-12 Human lung telocytes could promote the proliferation and angiogenesis of human pulmonary microvascular endothelial cells in vitro
  • 2014-12 Platelet dysfunction in injured patients
  • 2014-12 Low pH of interstitial fluid around hippocampus of the brain in diabetic OLETF rats
  • 2014-12 Role of solute carriers in response to anticancer drugs
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B0000X", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Biomedicine, general", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B12020", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Gene Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B1700X", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Molecular Medicine", 
            "type": "DefinedTerm"
          }
        ], 
        "description": "

    Molecular and Cellular Therapies (MCT) is the frontline journal for molecular mechanisms, preclinical and clinical research and development of gene-, peptide-, protein-, and cell-based therapies, including target identification and validation, safety, toxicity, efficacy, efficiency, pharmacokinetics, metabolism, formulation, delivery, pharmacovigilance, biomarkers, new drug application. MCT, central to clinical and translational medicine, will integrate genetics, cell biology, medicine, drug development, therapeutics, and biotechnology to improve the prognosis of patients.

    ", "editor": [ { "familyName": "Petersen", "givenName": "Bryon", "type": "Person" } ], "id": "sg:journal.1049594", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "2052-8426" ], "license": "Fully Open Access", "name": "Molecular and Cellular Therapies", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "49594" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "40591" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2013247783" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101624707" ] } ], "publisher": { "name": "BioMed Central", "type": "Organization" }, "publisherImprint": "BioMed Central", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1049594" ], "sdDataset": "journals", "sdDatePublished": "2021-01-19T05:00", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///pack/app/journals_20190313_sn_only.jsonl", "startYear": "2013", "type": "Periodical", "url": "http://molcelltherapies.biomedcentral.com/" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1049594'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1049594'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1049594'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1049594'


     

    This table displays all metadata directly associated to this object as RDF triples.

    55 TRIPLES      20 PREDICATES      26 URIs      19 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1049594 schema:about sg:ontologies/product-market-codes/B0000X
    2 sg:ontologies/product-market-codes/B12020
    3 sg:ontologies/product-market-codes/B1700X
    4 schema:description <p>Molecular and Cellular Therapies (MCT) is the frontline journal for molecular mechanisms, preclinical and clinical research and development of gene-, peptide-, protein-, and cell-based therapies, including target identification and validation, safety, toxicity, efficacy, efficiency, pharmacokinetics, metabolism, formulation, delivery, pharmacovigilance, biomarkers, new drug application. MCT, central to clinical and translational medicine, will integrate genetics, cell biology, medicine, drug development, therapeutics, and biotechnology to improve the prognosis of patients.</p>
    5 schema:editor N59f5ec666759400198ad9ba5498b858c
    6 schema:inLanguage en
    7 schema:isAccessibleForFree true
    8 schema:issn 2052-8426
    9 schema:license Fully Open Access
    10 schema:name Molecular and Cellular Therapies
    11 schema:productId N36aba37914fd48269f9ed1f5ac3082c2
    12 N4d29724034624fda9b7dfb05f57e0d21
    13 N88e9c9c4ba894f34b3b74c287e5fda03
    14 Nae19907105a54a37b7acbcfa1075e24e
    15 schema:publisher Nea3dca1e63b444cbb058925b5ad23d96
    16 schema:publisherImprint BioMed Central
    17 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1049594
    18 schema:sdDatePublished 2021-01-19T05:00
    19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    20 schema:sdPublisher N80b5b0c07c06436ea890600370ca1eb1
    21 schema:startYear 2013
    22 schema:url http://molcelltherapies.biomedcentral.com/
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset journals
    25 rdf:type schema:Periodical
    26 N36aba37914fd48269f9ed1f5ac3082c2 schema:name lccn_id
    27 schema:value 2013247783
    28 rdf:type schema:PropertyValue
    29 N39827640d55c49c5a325da99e2b90311 schema:familyName Petersen
    30 schema:givenName Bryon
    31 rdf:type schema:Person
    32 N4d29724034624fda9b7dfb05f57e0d21 schema:name springer_id
    33 schema:value 40591
    34 rdf:type schema:PropertyValue
    35 N59f5ec666759400198ad9ba5498b858c rdf:first N39827640d55c49c5a325da99e2b90311
    36 rdf:rest rdf:nil
    37 N80b5b0c07c06436ea890600370ca1eb1 schema:name Springer Nature - SN SciGraph project
    38 rdf:type schema:Organization
    39 N88e9c9c4ba894f34b3b74c287e5fda03 schema:name dimensions_id
    40 schema:value 49594
    41 rdf:type schema:PropertyValue
    42 Nae19907105a54a37b7acbcfa1075e24e schema:name nlm_unique_id
    43 schema:value 101624707
    44 rdf:type schema:PropertyValue
    45 Nea3dca1e63b444cbb058925b5ad23d96 schema:name BioMed Central
    46 rdf:type schema:Organization
    47 sg:ontologies/product-market-codes/B0000X schema:inDefinedTermSet sg:ontologies/product-market-codes/
    48 schema:name Biomedicine, general
    49 rdf:type schema:DefinedTerm
    50 sg:ontologies/product-market-codes/B12020 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    51 schema:name Gene Therapy
    52 rdf:type schema:DefinedTerm
    53 sg:ontologies/product-market-codes/B1700X schema:inDefinedTermSet sg:ontologies/product-market-codes/
    54 schema:name Molecular Medicine
    55 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...